Ke An

596 total citations · 1 hit paper
30 papers, 409 citations indexed

About

Ke An is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ke An has authored 30 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ke An's work include Pain Mechanisms and Treatments (10 papers), Neuropeptides and Animal Physiology (4 papers) and Nerve injury and regeneration (3 papers). Ke An is often cited by papers focused on Pain Mechanisms and Treatments (10 papers), Neuropeptides and Animal Physiology (4 papers) and Nerve injury and regeneration (3 papers). Ke An collaborates with scholars based in China, United States and Japan. Ke An's co-authors include En Chao, Linda J. Askew, Haihua Shu, Wenqi Huang, Lulu He, Ouwen Li, Quancheng Kan, Yueqin Wang, Masakazu Hayashida and Hui Yang and has published in prestigious journals such as Journal of Membrane Science, Journal of Pharmacology and Experimental Therapeutics and Journal of Ethnopharmacology.

In The Last Decade

Ke An

29 papers receiving 404 citations

Hit Papers

Aberrant m5C hypermethylation mediates intrinsic resistan... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke An China 12 199 85 81 65 51 30 409
Shuibing Liu China 9 152 0.8× 41 0.5× 76 0.9× 56 0.9× 83 1.6× 14 426
Majid Katebi Iran 13 210 1.1× 40 0.5× 47 0.6× 109 1.7× 63 1.2× 31 544
Huiqing Zhao China 13 176 0.9× 53 0.6× 86 1.1× 67 1.0× 22 0.4× 21 529
Yiwu Dai China 12 174 0.9× 35 0.4× 84 1.0× 114 1.8× 68 1.3× 29 547
Weihua Cai China 10 253 1.3× 138 1.6× 123 1.5× 111 1.7× 51 1.0× 17 518
Hongxia Cai China 12 198 1.0× 48 0.6× 81 1.0× 53 0.8× 62 1.2× 17 488
Youzhen Wei China 12 161 0.8× 84 1.0× 82 1.0× 36 0.6× 139 2.7× 23 448
Yulei Hao China 13 220 1.1× 50 0.6× 47 0.6× 74 1.1× 25 0.5× 28 528
Heyangzi Li China 14 328 1.6× 49 0.6× 69 0.9× 102 1.6× 110 2.2× 17 653
Xianjian Huang China 12 286 1.4× 30 0.4× 81 1.0× 75 1.2× 42 0.8× 27 703

Countries citing papers authored by Ke An

Since Specialization
Citations

This map shows the geographic impact of Ke An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke An more than expected).

Fields of papers citing papers by Ke An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke An. The network helps show where Ke An may publish in the future.

Co-authorship network of co-authors of Ke An

This figure shows the co-authorship network connecting the top 25 collaborators of Ke An. A scholar is included among the top collaborators of Ke An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke An. Ke An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Rui, Chang‐Yu Hung, Stoichko Antonov, et al.. (2024). Variations in γ′ formers and refractory elements for enhanced creep resistance and phase stability of an advanced Ni-based superalloy. Materials Advances. 5(22). 8847–8863. 2 indexed citations
2.
An, Ke, Jiaxin Fan, Bin Lin, & Yifeng Han. (2024). A lysosome-targeted fluorescent probe for fluorescence imaging of hypochlorous acid in living cells and in vivo. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 316. 124316–124316. 7 indexed citations
4.
Zhang, Xuran, Ke An, Xin Ge, et al.. (2024). NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation. Breast Cancer Research. 26(1). 94–94. 28 indexed citations
5.
Chen, Haoyang, Huihui Liu, Xiaowei Zhang, et al.. (2024). Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches. Frontiers in Pharmacology. 15. 1422033–1422033. 3 indexed citations
6.
Wang, Yueqin, Jingyao Wei, Ouwen Li, et al.. (2023). Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Molecular Cancer. 22(1). 81–81. 121 indexed citations breakdown →
7.
Wang, Mingming, et al.. (2023). A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs. Frontiers in Endocrinology. 14. 1193992–1193992. 4 indexed citations
8.
Li, Xianguo, Ke An, Zhenzhen Wang, et al.. (2023). Temsirolimus is a promising immunomodulatory agent for enhanced transplantation outcomes. Transplant Immunology. 81. 101952–101952. 1 indexed citations
11.
Peng, Zhe, et al.. (2021). Bone mesenchymal stem cells attenuate resiniferatoxin-induced neuralgia via inhibiting TRPA1-PKCδ-P38/MAPK-p-P65 pathway in mice. Brain Research Bulletin. 174. 92–102. 12 indexed citations
12.
Zhou, Zhengrong, Pan Huang, Zhuang Zhang, et al.. (2017). Comparative proteomic analysis of rats subjected to water immersion and restraint stress as an insight into gastric ulcers. Molecular Medicine Reports. 16(4). 5425–5433. 4 indexed citations
13.
An, Ke, et al.. (2017). hTERT-Immortalized Bone Mesenchymal Stromal Cells Expressing Rat Galanin via a Single Tetracycline-Inducible Lentivirus System. Stem Cells International. 2017. 1–11. 9 indexed citations
14.
Shu, Haihua, Masakazu Hayashida, Hideko Arita, et al.. (2011). Pentazocine-Induced Antinociception Is Mediated Mainly by μ-Opioid Receptors and Compromised by κ-Opioid Receptors in Mice. Journal of Pharmacology and Experimental Therapeutics. 338(2). 579–587. 17 indexed citations
15.
Shu, Haihua, Hideko Arita, Masakazu Hayashida, et al.. (2010). Anti-hypersensitivity effects of Shu-jing-huo-xue-tang, a Chinese herbal medicine, in CCI-neuropathic rats. Journal of Ethnopharmacology. 131(2). 464–470. 28 indexed citations
16.
An, Ke, Ying Xu, Hui Yang, et al.. (2009). Subarachnoid transplantation of immortalized galanin‐overexpressing astrocytes attenuates chronic neuropathic pain. European Journal of Pain. 14(6). 595–601. 24 indexed citations
17.
Shu, Haihua, Masakazu Hayashida, Wenqi Huang, et al.. (2008). The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine. Journal of Ethnopharmacology. 117(1). 158–165. 12 indexed citations
18.
Xu, Ying, Xuebi Tian, Ke An, Hui Yang, & Yuke Tian. (2007). Lumbar transplantation of immortalized enkephalin‐expressing astrocytes attenuates chronic neuropathic pain. European Journal of Pain. 12(4). 525–533. 22 indexed citations
19.
Xu, Ying, Yuke Tian, Xuebi Tian, Ke An, & Hui Yang. (2007). Construction and identification of immortalized rat astrocyte cell line expressing enkephalin.. PubMed. 10(6). 353–6. 2 indexed citations
20.
An, Ke, En Chao, & Linda J. Askew. (1980). Hand strength measurement instruments.. PubMed. 61(8). 366–8. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026